학술논문

WHIM Syndrome: from Pathogenesis Towards Personalized Medicine and Cure.
Document Type
Article
Source
Journal of Clinical Immunology. Aug2019, Vol. 39 Issue 6, p532-556. 25p.
Subject
*HEALING
*INDIVIDUALIZED medicine
*LYMPHOPENIA
*G protein coupled receptors
*WARTS
*CXCR4 receptors
*SYNDROMES
Language
ISSN
0271-9142
Abstract
WHIM syndrome is a rare combined primary immunodeficiency disease named by acronym for the diagnostic tetrad of warts, hypogammaglobulinemia, infections, and myelokathexis. Myelokathexis is a unique form of non-cyclic severe congenital neutropenia caused by accumulation of mature and degenerating neutrophils in the bone marrow; monocytopenia and lymphopenia, especially B lymphopenia, also commonly occur. WHIM syndrome is usually caused by autosomal dominant mutations in the G protein-coupled chemokine receptor CXCR4 that impair desensitization, resulting in enhanced and prolonged G protein- and β-arrestin-dependent responses. Accordingly, CXCR4 antagonists have shown promise as mechanism-based treatments in phase 1 clinical trials. This review is based on analysis of all 105 published cases of WHIM syndrome and covers current concepts, recent advances, unresolved enigmas and controversies, and promising future research directions. [ABSTRACT FROM AUTHOR]